C M van der Feltz-Cornelis1, A P Aldenkamp. 1. Department of Psychopathology, Netherlands Epilepsy Centre SEIN, Heemstede, and Neurology Department, University of Maastricht, The Netherlands. cfeltz@trimbos.nl
Abstract
OBJECTIVE: The purpose of this study was to evaluate the effectiveness and safety of methylphenidate treatment in epilepsy patients with comorbid adult attention deficit hyperactivity disorder (ADHD). METHODS: Six of 156 consecutive patients attending a tertiary epilepsy clinic for diagnostic evaluation of new seizures, 3 patients with epilepsy and 3 patients with psychogenic non-epileptic seizures, were diagnosed with comorbid adult ADHD. These 6 patients entered an open trial of methylphenidate 10 mg twice daily. Clinical improvement was assessed at 6 weeks of follow-up. RESULTS: Both groups showed clinical improvement of ADHD symptoms during treatment. None of the patients with comorbid epilepsy experienced adverse effects on seizure control or antiepileptic drug use. CONCLUSION: In this open trial methylphenidate was safely used in patients with epilepsy and adult ADHD. It was effective against adult ADHD, and there were no adverse effects on seizure severity and frequency. A randomized study is needed to further establish effectiveness and safety.
OBJECTIVE: The purpose of this study was to evaluate the effectiveness and safety of methylphenidate treatment in epilepsypatients with comorbid adult attention deficit hyperactivity disorder (ADHD). METHODS: Six of 156 consecutive patients attending a tertiary epilepsy clinic for diagnostic evaluation of new seizures, 3 patients with epilepsy and 3 patients with psychogenic non-epilepticseizures, were diagnosed with comorbid adult ADHD. These 6 patients entered an open trial of methylphenidate 10 mg twice daily. Clinical improvement was assessed at 6 weeks of follow-up. RESULTS: Both groups showed clinical improvement of ADHD symptoms during treatment. None of the patients with comorbid epilepsy experienced adverse effects on seizure control or antiepileptic drug use. CONCLUSION: In this open trial methylphenidate was safely used in patients with epilepsy and adult ADHD. It was effective against adult ADHD, and there were no adverse effects on seizure severity and frequency. A randomized study is needed to further establish effectiveness and safety.
Authors: Chris Eaton; Kenneith Yong; Victoria Walter; Gashirai K Mbizvo; Sinead Rhodes; Richard Fm Chin Journal: Cochrane Database Syst Rev Date: 2022-07-13
Authors: Isabell Brikell; Qi Chen; Ralf Kuja-Halkola; Brian M D'Onofrio; Kelsey K Wiggs; Paul Lichtenstein; Catarina Almqvist; Patrick D Quinn; Zheng Chang; Henrik Larsson Journal: Epilepsia Date: 2019-01-25 Impact factor: 5.864
Authors: Mesha-Gay Brown; Danielle A Becker; John R Pollard; Christopher Todd Anderson Journal: Curr Neurol Neurosci Rep Date: 2013-06 Impact factor: 5.081
Authors: Amy E Williams; Julianne M Giust; William G Kronenberger; David W Dunn Journal: Neuropsychiatr Dis Treat Date: 2016-02-09 Impact factor: 2.570
Authors: Kelsey K Wiggs; Zheng Chang; Patrick D Quinn; Kwan Hur; Robert Gibbons; David Dunn; Isabell Brikell; Henrik Larsson; Brian M D'Onofrio Journal: Neurology Date: 2018-02-23 Impact factor: 9.910